Billable/Specific ICD-10-CM Codes - Page 31

There are 35,750 ICD-10-CM codes which are billable/specific and can be used to indicate a diagnosis for reimbursement purposes as there are no codes with a greater level of specificity under each code.

  • D81.9 - Combined immunodeficiency, unspecified
  • D82.0 - Wiskott-Aldrich syndrome
  • D82.1 - Di George's syndrome
  • D82.2 - Immunodeficiency with short-limbed stature
  • D82.3 - Immunodeficiency following hereditary defective response to Epstein-Barr virus
  • D82.4 - Hyperimmunoglobulin E [IgE] syndrome
  • D82.8 - Immunodeficiency associated with other specified major defects
  • D82.9 - Immunodeficiency associated with major defect, unspecified
  • D83.0 - Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
  • D83.1 - Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
  • D83.2 - Common variable immunodeficiency with autoantibodies to B- or T-cells
  • D83.8 - Other common variable immunodeficiencies
  • D83.9 - Common variable immunodeficiency, unspecified
  • D84.0 - Lymphocyte function antigen-1 [LFA-1] defect
  • D84.1 - Defects in the complement system
  • D84.81 - Immunodeficiency due to conditions classified elsewhere
  • D84.821 - Immunodeficiency due to drugs
  • D84.822 - Immunodeficiency due to external causes
  • D84.89 - Other immunodeficiencies
  • D84.9 - Immunodeficiency, unspecified
  • D86.0 - Sarcoidosis of lung
  • D86.1 - Sarcoidosis of lymph nodes
  • D86.2 - Sarcoidosis of lung with sarcoidosis of lymph nodes
  • D86.3 - Sarcoidosis of skin
  • D86.81 - Sarcoid meningitis
  • D86.82 - Multiple cranial nerve palsies in sarcoidosis
  • D86.83 - Sarcoid iridocyclitis
  • D86.84 - Sarcoid pyelonephritis
  • D86.85 - Sarcoid myocarditis
  • D86.86 - Sarcoid arthropathy
  • D86.87 - Sarcoid myositis
  • D86.89 - Sarcoidosis of other sites
  • D86.9 - Sarcoidosis, unspecified
  • D89.0 - Polyclonal hypergammaglobulinemia
  • D89.1 - Cryoglobulinemia
  • D89.2 - Hypergammaglobulinemia, unspecified
  • D89.3 - Immune reconstitution syndrome
  • D89.40 - Mast cell activation, unspecified
  • D89.41 - Monoclonal mast cell activation syndrome
  • D89.42 - Idiopathic mast cell activation syndrome
  • D89.43 - Secondary mast cell activation
  • D89.44 - Hereditary alpha tryptasemia
  • D89.49 - Other mast cell activation disorder
  • D89.810 - Acute graft-versus-host disease
  • D89.811 - Chronic graft-versus-host disease
  • D89.812 - Acute on chronic graft-versus-host disease
  • D89.813 - Graft-versus-host disease, unspecified
  • D89.82 - Autoimmune lymphoproliferative syndrome [ALPS]
  • D89.831 - Cytokine release syndrome, grade 1
  • D89.832 - Cytokine release syndrome, grade 2
  • D89.833 - Cytokine release syndrome, grade 3
  • D89.834 - Cytokine release syndrome, grade 4
  • D89.835 - Cytokine release syndrome, grade 5
  • D89.839 - Cytokine release syndrome, grade unspecified
  • D89.84 - IgG4-related disease
  • D89.89 - Other specified disorders involving the immune mechanism, not elsewhere classified
  • D89.9 - Disorder involving the immune mechanism, unspecified
  • E00.0 - Congenital iodine-deficiency syndrome, neurological type
  • E00.1 - Congenital iodine-deficiency syndrome, myxedematous type
  • E00.2 - Congenital iodine-deficiency syndrome, mixed type
  • E00.9 - Congenital iodine-deficiency syndrome, unspecified
  • E01.0 - Iodine-deficiency related diffuse (endemic) goiter
  • E01.1 - Iodine-deficiency related multinodular (endemic) goiter
  • E01.2 - Iodine-deficiency related (endemic) goiter, unspecified
  • E01.8 - Other iodine-deficiency related thyroid disorders and allied conditions
  • E03.0 - Congenital hypothyroidism with diffuse goiter
  • E03.1 - Congenital hypothyroidism without goiter
  • E03.2 - Hypothyroidism due to medicaments and other exogenous substances
  • E03.3 - Postinfectious hypothyroidism
  • E03.4 - Atrophy of thyroid (acquired)
  • E03.5 - Myxedema coma
  • E03.8 - Other specified hypothyroidism
  • E03.9 - Hypothyroidism, unspecified
  • E04.0 - Nontoxic diffuse goiter
  • E04.1 - Nontoxic single thyroid nodule
  • E04.2 - Nontoxic multinodular goiter
  • E04.8 - Other specified nontoxic goiter
  • E04.9 - Nontoxic goiter, unspecified
  • E05.00 - Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
  • E05.01 - Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
  • E05.10 - Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm
  • E05.11 - Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm
  • E05.20 - Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm
  • E05.21 - Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm
  • E05.30 - Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm
  • E05.31 - Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm
  • E05.40 - Thyrotoxicosis factitia without thyrotoxic crisis or storm
  • E05.41 - Thyrotoxicosis factitia with thyrotoxic crisis or storm
  • E05.80 - Other thyrotoxicosis without thyrotoxic crisis or storm
  • E05.81 - Other thyrotoxicosis with thyrotoxic crisis or storm
  • E05.90 - Thyrotoxicosis, unspecified without thyrotoxic crisis or storm
  • E05.91 - Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
  • E06.0 - Acute thyroiditis
  • E06.1 - Subacute thyroiditis
  • E06.2 - Chronic thyroiditis with transient thyrotoxicosis
  • E06.3 - Autoimmune thyroiditis
  • E06.4 - Drug-induced thyroiditis
  • E06.5 - Other chronic thyroiditis
  • E06.9 - Thyroiditis, unspecified
  • E07.0 - Hypersecretion of calcitonin